M1402 Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group billable
M1403 Patients with baseline and follow-up promis surveys documented in the medical record billable
M1404 Patients on a therapeutic clinical trial billable
M1405 Patients with recurrence/disease progression billable
M1406 Patients who leave the practice during the follow-up period billable
M1407 Patients who died during the follow-up period billable
M1408 Patients who have germline brca testing completed before diagnosis of epithelial ovarian, fallopian tube, or primary peritoneal cancer billable
M1409 Patients who received germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosis billable
M1410 Patients who did not have germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosis billable
M1411 Currently on first-line immune checkpoint inhibitors without chemotherapy billable
M1412 Patients with metastatic nsclc with epidermal growth factor receptor (egfr) mutations, alk genomic tumor aberrations, or other targetable genomic abnormalities with approved first-line targeted therapy, such as nsclc with ros1 rearrangement, braf v600e mutation, ntrk 1/2/3 gene fusion, met ex14 skipping mutation, and ret rearrangement billable
M1413 Patients who had a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy billable
M1414 Documentation of medical reason(s) for not performing the pd-l1 biomarker expression test prior to initiation of first-line immune checkpoint inhibitor therapy (e.g., patient is in an urgent or emergent situation where delay of treatment would jeopardize the patient's health status; other medical reasons/contraindication) billable
M1415 Patients who did not have a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy billable
M1416 Patient received hospice services any time during the performance period billable
M1417 Patients who are up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination billable
M1418 Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination because of a medical contraindication documented by clinician billable
M1419 Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination billable
M1420 Complete ophthalmologic care mips value pathway billable
M1421 Dermatological care mips value pathway billable
M1422 Gastroenterology care mips value pathway billable
M1423 Optimal care for patients with urologic conditions mips value pathway billable
M1424 Pulmonology care mips value pathway billable
M1426 Encounters conducted via telehealth billable
M1427 Documentation of medical reason(s) for performing a bone scan (including documented pain related to prostate cancer, salvage therapy, other medical reasons) billable
M1428 Patients who have bilateral absence of eyes any time during the patient's history through the end of the measurement period billable
M1429 Retinal exam finding with evidence of retinopathy in left, right or both eyes with severity level documented billable
M1430 Retinal exam finding without evidence of retinopathy in both eyes with severity level documented (in measurement year or in the prior year) billable
M1431 Encounters conducted via telehealth billable
M1432 Encounters conducted via telehealth billable
M1433 Patient on oral chemotherapy on or within 30 days before denominator eligible encounter billable
M1434 Patient on oral chemotherapy on or within 30 days after denominator eligible encounter billable
M1435 Patient on oral chemotherapy during the performance period billable
M1436 Encounters conducted via telehealth billable
M1437 Encounters conducted via telehealth billable
M1438 Time last known well to hospital arrival less than or equal to 3.5 hours (<= 210 minutes) billable
M1439 Significant ocular conditions that impact the visual outcome of surgery billable
M1440 Encounters conducted via telehealth billable
M1441 Encounter corresponds to initial diagnosis of sleep apnea or first contact with sleep apnea diagnosed patient billable
M1442 Encounters conducted via telehealth billable
M1443 Encounters conducted via telehealth billable
M1444 Delivery at < 39 weeks of gestation billable
M1445 Postpartum care visit before or at 12 weeks of giving birth billable
M1446 Patients who died any time prior to the end of the measure assessment period billable
M1447 Patients with an active diagnosis of bipolar disorder any time prior to the end of the measure assessment period billable
M1448 Patients with an active diagnosis of personality disorder any time prior to the end of the measure assessment period billable
M1449 Patients with an active diagnosis of schizophrenia or psychotic disorder any time prior to the end of the measure assessment period billable
M1450 Patients who received hospice or palliative care service any time during denominator identification period or the measure assessment period billable
M1451 Patients with an active diagnosis of pervasive developmental disorder any time prior to the end of the measure assessment period billable
M1452 Patient ever had a diagnosis of dementia billable
M1453 Patients with a pre-operative visual acuity better than 20/40 billable
M1457 Patient had a diagnosis of asthma with any contact during the current or prior performance period or had asthma present on an active problem list any time during the performance period billable
M1458 Patient died prior to the end of the performance period billable
M1459 Patient was in hospice or receiving palliative care services at any time during the performance period billable
M1460 Diagnosis for chronic obstructive pulmonary disease, emphysema, cystic fibrosis, or acute respiratory failure billable
M1461 Patient diagnosis for chronic hepatitis c billable
M1462 Patients with clinical indications for imaging of the head billable
M1463 Documentation of at least two attempts to follow up with patient within 180 days of treatment billable
M1464 No documentation of at least two attempts to follow up with patient within 180 days of treatment billable
M1465 Patient follow up more than 180 days after treatment billable
M1466 Patient had a lumbar fusion on the same date as the discectomy/laminectomy procedure billable
M1467 Patients with an existing diagnosis of lynch syndrome billable
M1468 Patient received recommended doses of hepatitis b vaccination based on age billable
M1469 Patient has a history of hepatitis b illness or received a hepatitis b surface antigen, hepatitis b surface antibody, or total antibody to hepatitis b core antigen test with a positive result any time before or during the measurement period billable
M1470 Documentation of medical reason(s) for not administering hepatitis b vaccine (e.g., prior anaphylaxis due to the hepatitis b vaccine) billable
M1471 Documentation that patient is a medicare fee-for-service beneficiary and without additional supplementary insurance coverage for whom hep b vaccination is not reimbursable under current medicare part b coverage rules billable
M1472 Patient did not receive recommended doses of hepatitis b vaccination based on age billable
M1473 Patient situations, at any point during the denominator identification period, where the patient's functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools, such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders billable
M1474 Patients with diagnosis of dementia billable
M1475 Patients with diagnosis of huntington's disease billable
M1476 Patients with diagnosis of cognitive impairment or alzheimer's disease billable
M1479 Patients whose functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders billable
M1480 Patients whose functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders billable
M1481 Patients receiving hospice or palliative care or who died during the measurement period billable
M1482 Positive/detectable hepatitis c virus quantitative or qualitative rna test result during the denominator identification period billable
M1483 Patients who achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period billable
M1484 Patients who did not have a repeat hcv rna labs performed for medical reasons documented by clinician (e.g., patient with limited life expectancy, delay in treatment of hcv related to treatment of hiv, hbv, hepatocellular carcinoma, decompensated cirrhosis) billable
M1485 Patients who did not achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period billable
M1486 Patients admitted to a skilled nursing facility (snf) during the period of evaluation billable
M1487 Patients in hospice in the year before or during the period of evaluation billable
M1488 Patients with a diagnosis for dementia in the year before or during the period of evaluation billable
M1493 Documentation of falls not performed due to medical reasons (e.g., syncope, vertigo and related disorders, restless leg syndrome, tourette syndrome/tic disorder, back pain, concussion/mild traumatic brain injury (mtbi), cervical dystonia, or epilepsy) billable
M1494 Patients that reported a fall since the last visit billable
M1495 Patients that reported a fall occurred who had a plan of care for falls documented or patients that did not report a fall billable
M1496 Patients that had a fall who did not have a plan of care for falls documented or do not have documentation of being assessed for falls billable
M1497 Documentation of falls not performed due to medical reasons (e.g., syncope, vertigo and related disorders, restless leg syndrome, tourette syndrome/tic disorder, back pain, concussion/mild traumatic brain injury (mtbi), cervical dystonia, or epilepsy) billable
M1498 Diagnostic radiology mips value pathway billable
M1499 Interventional radiology mips value pathway billable